CELL OF ORIGIN COMBINED WITH CNS INTERNATIONAL PROGNOSTIC INDEX IMPROVES IDENTIFICATION OF DLBCL PATIENTS WITH HIGH CNS RELAPSE RISK AFTER INITIAL IMMUNOCHEMOTHERAPY
Klanova, M., Sehn, L.H., Bence-Bruckler, I., Cavallo, F., Jin, J., Martelli, M., Stewart, D., Vitolo, U., Zaja, F., Zhang, Q., Mattiello, F., Oestergaard, M.Z., Fingerle-Rowson, G.R., Nielsen, T., TrnVolume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_25
Date:
June, 2017
File:
PDF, 150 KB
english, 2017